MoneyWorks4Me

MPS informs about earnings presentation

16 May 2023 Evaluate

Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS has informed that it enclosed the Earnings Presentation on Audited Financial Results of the Company for the Fourth Quarter (Q4) and Financial Year ended 31 March 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..